Literature DB >> 8853336

Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla.

T Saigusa1, M Iriki, J Arita.   

Abstract

The role of endogenous angiotensin II (ANG II) at the level of the rostral (RVLM) and caudal ventrolateral medulla (CVLM) in the control of sympathetic baroreflex function was investigated in urethan-anesthetized rabbits. The baroreflex relationship between mean arterial pressure and integrated renal sympathetic nerve activity (RSNA) was compared before and during microinfusion of saralasin, an ANG II receptor antagonist into RVLM or CVLM. The infusion of saralasin (20 pmol/min) into RVLM reduced the upper plateau, the range, and the range-dependent gain of the baroreflex, as well as the resting level of RSNA. The infusion of saralasin into CVLM augmented the upper plateau, the reflex range, and the range-dependent gain, whereas it did not alter the resting level of RSNA or mean arterial pressure. These results suggest that 1) the ANG II networks in RVLM are tonically active, influencing the resting level of the sympathetic outflow and facilitating the sympathetic baroreflex function, and 2) the ANG II networks in CVLM do not significantly influence the sympathetic activity in the resting state but exert an inhibitory effect on the baroreflex response when arterial pressure falls below the resting level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853336     DOI: 10.1152/ajpheart.1996.271.3.H1015

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Anna M D Watson; Andrew M Allen; Clive N May
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

Review 2.  Differential control of efferent sympathetic activity revisited.

Authors:  Masami Iriki; Eckhart Simon
Journal:  J Physiol Sci       Date:  2012-05-22       Impact factor: 2.781

3.  Spinophilin regulates central angiotensin II-mediated effect on blood pressure.

Authors:  Andrey C da Costa Goncalves; Marco Antonio Peliky Fontes; Enno Klussmann; Fatimunnisa Qadri; Jürgen Janke; Maik Gollasch; Johanna Schleifenbaum; Dominik Müller; Jens Jordan; Jens Tank; Friedrich C Luft; Volkmar Gross
Journal:  J Mol Med (Berl)       Date:  2011-08-05       Impact factor: 4.599

Review 4.  Modulation of angiotensin II signaling following exercise training in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Hanjun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 5.  The role of the central nervous system in hypertension.

Authors:  J M Wyss; S H Carlson
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

6.  Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure.

Authors:  Liang Xiao; Lie Gao; Eric Lazartigues; Irving H Zucker
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

Review 7.  Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

Authors:  I H Zucker; J L Liu
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

8.  Cardiovascular effect of angiotensin-(1-12) in the caudal ventrolateral medullary depressor area of the rat.

Authors:  Tetsuya Kawabe; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

9.  Effect of hypothermia on baroreflex control of heart rate and renal sympathetic nerve activity in anaesthetized rats.

Authors:  R Sabharwal; J H Coote; E J Johns; S Egginton
Journal:  J Physiol       Date:  2004-02-20       Impact factor: 5.182

10.  Acute shifts of baroreflex control of renal sympathetic nerve activity induced by treadmill exercise in rats.

Authors:  Kenju Miki; Misa Yoshimoto; Momoko Tanimizu
Journal:  J Physiol       Date:  2003-01-31       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.